Shattuck Labs Provides Corporate Update and Highlights Upcoming Key Milestones in 2024

AUSTIN, TX and DURHAM, NC, Jan. 08, 2024 -- Shattuck Labs, Inc. , a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic...

Related Keywords

United States ,North Carolina ,San Francisco ,California ,Texas ,American ,Conor Richardson ,Taylor Schreiber ,Nasdaq ,Exchange Commission ,American Society Of Clinical Oncology ,Shattuck Labs Inc ,American Society Of Hematology Annual Meeting ,Chief Executive Officer ,Resistant Ovarian Cancer ,American Society ,Clinical Oncology ,Risk Myelodysplastic Syndromes ,Acute Myeloid Leukemia ,Hematology Annual ,Milestones Expected ,Financial Guidance ,Healthcare Conference ,Corporate Presentation ,Shattuck Labs ,Agonist Redirected Checkpoint ,Annual Report ,Safe Harbor ,Private Securities Litigation Reform Act ,Media Contact ,Investor Relations ,Markets ,